A urine-based cancer risk screening kit developed by a Japanese startup is showing promise in detecting cancer at the earliest stage using non-invasive means. The test kit from Craif Inc., a spin-off ...

The 'miSignal' test kit is able to assess the risk of up to seven cancer types using only a small urine sample.

Its approval is based on a pivotal trial involving more than 1,000 patients, led by the Mayo Clinic, which found that the device had a sensitivity of 96% across all 224 skin cancer cases in the ...

The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...

Women with breast cancer in England and Wales will soon be able to access a new diagnostic based on an injectable magnetic marker liquid called Magtrace that will identify if the disease has ...

Objectives To examine the accuracy and impact of artificial intelligence (AI) software assistance in lung cancer screening using CT. Methods A systematic review of CE-marked, AI-based software for ...

Accurate detection of circulating tumor cells (CTCs) remains a critical challenge in clinical oncology due to limitations in sensitivity, cost-effectiveness, and operational complexity. In this study, ...